Blog
3 Reasons Crocs' Ambitious Growth Projections Might Be for Real
Here's a sentence I never thought I'd write: Crocs (NASDAQ: CROX) is the global leader in clogs, and clogs are picking up steam.
Regardless of your opinion on the polarizing footwear, the
Here's Why the Market Loved Lululemon's Q2 Results
On Sept. 8, apparel and fitness company Lululemon Athletica (NASDAQ: LULU) reported financial results for the second quarter of 2021. The company beat expectations and raised its guidance, much to
1 Recent IPO in the Red-Hot Pet Industry
Pet owners are always searching for new and convenient ways to get their pets the care they need, and that's where recent IPO Rover Group (NASDAQ: ROVR) comes in. In this Fool Live video clip
Why Roblox and Fortnite Are Strong Leaders in the Metaverse Race
Today's video focuses on recent news affecting Roblox (NYSE: RBLX), its most recent metrics showing the strength of the gaming market, and how the metaverse is becoming a reliable tool for companies
Why PancakeSwap Is a Top Crypto to Buy Now
PancakeSwap (CRYPTO: CAKE) was introduced just a year ago this month, but it has quickly became the largest automated crypto market maker -- a provider of trading liquidity -- on the Binance Smart
Is Skillz Stock a Good Long-Term Investment?
Mobile gaming company Skillz (NYSE: SKLZ) has ridden the meme stock roller coaster in 2021 as the number of shares shorted rose to nearly 61 million at the end of August, representing 15% of the
This Stock Could Be a Big Winner of Infrastructure Spending
While there is still quite a political process that needs to play out, the reality is that trillions of dollars need to be spent on infrastructure in the United States, and sooner rather than later
Better FAANG Stock: Facebook vs. Apple
Facebook (NASDAQ: FB) and Apple (NASDAQ: AAPL) have repeatedly butted heads over privacy standards and targeted ads over the past year. Apple's iOS 14.5 update, which rolled out in April, allowed
Disney Is Winning Against Netflix in This Crucial Market
India is one of Netflix's (NASDAQ: NFLX) key markets internationally thanks to its huge population, increasing smartphone penetration, and the adoption of faster wireless networks. Not surprisingly
Good News for Macy's: Retail Spending Keeps Rising
On Sep. 16, the U.S. Department of Commerce released retail sales data for August. The figures revealed a consumer with a healthy appetite for spending, and overall sales increased from the prior
September Sell-Off: Best Dividend Stocks to Buy Now
For the stock market, September is often the cruelest month. In fact, going back to 1928, September is historically the worst month for stock market returns, averaging -0.1% since that time.
This
2 Top Marijuana Stocks to Buy for the Long Haul
The fast-growing marijuana industry is full of opportunities for long-term investors. From growers to retailers to ancillary providers, there's something for every type of investor, no matter their
3 Reasons to Buy Zoom Video, and 1 Reason to Sell
Historians will find few companies more associated with the coronavirus pandemic than Zoom Video (NASDAQ: ZM). The company's name quickly became a verb as friends, family, and co-workers tried to
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
Axsome Therapeutics (NASDAQ: AXSM) is close to earning approval for a new depression drug that could generate billions in annual revenues. Unfortunately, the proposed action date for the Food and
Market Sell-Off Fears: Where to Invest $1,000 Right Now
Several red flags spooked investors on Monday, Sept. 20, as the S&P 500 fell 1.7% amid signs of a potential sell-off. September is usually considered a bad month for the stock market. Major indexes
5 Strategies to Boost Your Social Security Checks at Any Age
There's a common misconception that Social Security benefits are set in stone, but they're not. Whether you're too young to claim, of claiming age but not signed up, or already receiving benefits
3 Things About Tilray That Smart Investors Know
The merger between two Canadian pot companies Aphria and Tilray (NASDAQ: TLRY) has been the highlight of the industry this year. Tilray, which was once a smaller company, now holds a market cap of
1 Small-Cap IPO With a Massive Market Opportunity
The global demand for data is growing exponentially, and the data center industry is one of the biggest beneficiaries. And while the big players like Equinix (NASDAQ: EQIX) and Digital Realty Trust
Here's Why Palo Alto Networks Stock Could Go Higher
It was just over two months ago that Palo Alto Networks (NYSE: PANW) stock looked all set to break out of mediocrity and lift off on the back of its fast revenue growth, improving outlook, and a
2 FAANG Stocks to Buy and 1 to Avoid in the Fourth Quarter
For more than 12 years, growth stocks have been the talk of Wall Street. That's because historically low lending rates and ongoing quantitative easing from the nation's central bank have rolled out
3 Relatively Safe Pharma Stocks You Can Buy Right Now
Volatility has been on full display in the stock market this week. The wild swings are enough to cause many investors to look for safe havens to park their hard-earned cash. One option to consider
3 No-Brainer Stocks to Buy in a Correction
A market correction is a great time to go shopping for unstoppable stocks. During corrections, these shares often take a bit of a pause -- offering us a decent entry point. So, what type of stocks
2 Unstoppable Stocks That Could Turn $200,000 Into $1 Million by 2030
For investors who are sitting on cash, watching the S&P 500 index move higher this year with only minor corrections has been a frustrating experience. Missing out on big returns can be stressful
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
Cathie Wood believes in the potential of gene editing. She stated last December that the "biggest upside surprises are going to come from the genomic space."
It's not surprising that Wood's ARK
Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years
There's a big gap between the year-to-date performances of the top two exchange-traded funds (ETFs) focusing on biotechs. The iShares Biotechnology ETF (NASDAQ: IBB) has delivered a solid


